Born in Melsungen, Germany, in 1979, Anna Maria Braun is a German businesswoman, lawyer, and the CEO of B. Braun Melsungen AG, a global leader in medical devices and pharmaceutical products. She represents the sixth generation of family leadership in a company with a history stretching back over 180 years.

Her education was rigorous and global: she attended the prestigious United World College of the Atlantic (UWC) in the UK, completed a year-long intensive Chinese language course at the Beijing Language and Culture University, and finally earned a Master of Laws (LL.M.) degree from Georgetown University in Washington, D.C. This background in law and global affairs, rather than medicine, provided her with the corporate and regulatory expertise necessary to steer a massive, multinational healthcare firm. After working briefly as a lawyer for a major German law firm, she joined the family business in 2009.

Anna Maria Braun’s career ascent within B. Braun was meticulously planned to prepare her for the top leadership role. She began her in-house career in 2009 and quickly gained international operational experience, heading the subsidiary B. Braun Medical Industries in Malaysia in 2013. This provided her with crucial insights into Asian markets, a key growth region for the company.

In 2016, she joined the board of B. Braun Melsungen AG, specifically overseeing Asia-Pacific operations. Her ultimate ascension came in 2019 when she took over as CEO of the entire family business, becoming the first woman to hold the position in the company's long history. Her leadership mandate is to drive digital transformation and global expansion while maintaining the company's private, family-owned identity, a significant achievement in the highly competitive and heavily regulated medical technology sector. She also holds influential external board positions, notably as a member of the Advisory Board of the Oetker Group.

Anna Maria Braun’s social impact is inherent in B. Braun’s mission: providing critical medical devices and solutions that enhance patient health and safety globally. The company's long-term commitment to quality and innovation directly contributes to global healthcare standards.

On a personal and institutional level, she is dedicated to public health governance, serving as a Member of the Board of Trustees for the Robert Koch Foundation, an organization that supports medical research and scientific excellence in Germany. Her leadership is focused on maintaining the ethical standards of a centuries-old family business, ensuring that B. Braun's growth is directly tied to improving global healthcare outcomes.

Anna Maria Braun projects the dynamic, yet deeply traditional, style of a modern German industrial CEO. Her attire is consistently professional, elegant, and tailored, favoring high-end European designer wear that communicates authority and precision, befitting her background as both a lawyer and an executive in the medical technology sector.

Her lifestyle is centered in Melsungen, the company's historic base, reflecting her commitment to the family's roots. As a mother of three and a global CEO, her luxury is the strategic control over a vast, private multinational that operates in over 60 countries. Her private travel is executive-focused, leveraging B. Braun's global network, underscoring a life of immense professional responsibility and quiet, generational affluence.